Developing new therapeutic strategies for brain cancer

Johns, Terry (Primary Chief Investigator (PCI))

Hudson Institute - Centre for Cancer Research

Project: Research

Status	Relinquished
Effective start/end date	1/01/17 → 27/11/17

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$763,845.00

2 Article

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3
Greenall, S. A., Donoghue, J., Johns, T. G. & Adams, T. E., 1 Aug 2018, In: Translational Oncology. 11, 4, p. 971-978 8 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

5 Citations (Scopus)
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
Greenall, S. A., Lim, Y. C., Mitchell, C. B., Ensbey, K. S., Stringer, B. W., Wilding, A. L., O'Neill, G. M., McDonald, K. L., Gough, D. J., Day, B. W. & Johns, T. G., 1 Jan 2017, In: Oncogenesis. 6, 5, 13 p., e336.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

55 Citations (Scopus)

FlowCore
Fryga, A. (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility
Monash Micro Imaging
Firth, S. (Manager), Fulcher, A. (Operator), Chernyavskiy, O. (Operator), Rzeszutek, M. (Other), Potter, D. (Manager), Hilsenstein, V. (Operator), Nunez-Iglesias, J. (Other), Cody, S. (Manager), Carmichael, I. (Operator), Kouskousis, B. (Other), Creed, S. (Manager) & Ballerin, G. (Operator)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility